Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR

We reported a relevant activity of the combination between sorafenib and octreotide long-acting release (LAR) in advanced hepatocellular carcinoma (HCC) patients. In this work, we have studied if oxidative stress in both serum and peripheral blood mononuclear cells (PBMC) and pERK activation status...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Caraglia, M, Giuberti, G, Marra, M, Addeo, R, Montella, L, Murolo, M, Sperlongano, P, Vincenzi, B, Naviglio, S, Prete, S Del, Abbruzzese, A, Stiuso, P
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122065/
https://ncbi.nlm.nih.gov/pubmed/21525937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2011.34
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados